Hintergrund: Das Karzinosarkom des Uterus ist ein seltener maligner Tumor mit äußerst schlechter Prognose. Aufgrund der wenigen beschriebenen Fälle besteht kaum Evidenz in Bezug auf mögliche Behandlungsoptionen. Eine Verbesserung der unbefriedigenden Therapiesituation ist erforderlich. Falldarstellung: Beschrieben wird das Management eines zum Zeitpunkt der Primärdiagnose weit fortgeschrittenen Karzinosarkoms des Uterus im Stadium FIGO 4 bei einer 67-jährigen Patientin unter Einsatz von mehrfachen chirurgischen Interventionen, Strahlentherapie, Polychemotherapie sowie der komplementären Anwendung von Elementen der Ayurveda-Medizin. Das bislang 3-jährige Follow-up erbrachte keinen Hinweis auf eine Fernmetastasierung. Eine hohe Lebensqualität konnte kontinuierlich gewährleistet werden. Schlussfolgerung: Auch Tumorentitäten mit infauster Prognose können unter Nutzung aller zur Verfügung stehenden Ressourcen beherrschbar sein und ermöglichen eine zufriedenstellende Lebensqualität ohne gravierende subjektive Einschnitte über einen längeren Zeitabschnitt. Dazu kann der komplementäre Einsatz eines naturheilkundlichen Systems wie der Ayurveda-Medizin hilfreich sein.

Journal Section:
Falldarstellung <i>· </i> Case Report
Keywords:
Ayurveda, Komplementärmedizin, Pflanzliche Arzneimittel, Stationäre Patienten, Onkologie
1.
Brandt M, Marzotko F: Beitrag zum Karzinosarkom des Uterus. Zentralblatt für allgemeine Pathologie und pathologische Anatomie 1977;121:129-133.
[PubMed]
2.
Bartel U, Elling D: Behandlungsergebnisse beim Uterussarkom. Zentralblatt für Gynäkologie 1982; 104:678-684.
[PubMed]
3.
Atzinger A, Ries G, Hötzinger H, Hermans M, Pfändner K: Zur Klinik, Therapie und Prognose des Uterussarkoms. Strahlentherapie 1982;158:210-216.
[PubMed]
4.
Stegner H: Klinik der Uterussarkome. Pathol Res Pract 1980;169:120-126.
[PubMed]
5.
Viereck V, Huschmand-Nia A, Pauer H, Emons G, Krauss T: Diagnostik und Therapie der Uterussarkome. ZBL Gynakol 2002;124:506-510.
[PubMed]
https://doi.org/10.1055/s-2002-39577
6.
Harter P: Handbuch Gynäkologische Onkologie: Sarkome. Wiesbaden, Med Update, 2010.
7.
Köhler G, Evert M: Uterine Sarkome und Mischtumoren. Berlin, De Gruyter, 2009.
8.
Köhler G: Adjuvante und/oder Strahlentherapie beim Uterussarkom - gibt es Standards? Med Report 2006;30:2-3.
9.
Sharma DN, Rath GK, Kumar S, et al.: Clinical outcome of patients with uterine sarcomas. J Cancer Res Ther 2011;7:270-274.
[PubMed]
https://doi.org/10.4103/0973-1482.87011
10.
Gurumurthy M, Somoye G, Cairns M, et al.: An update on the management of uterine carcinosarco-ma. Obstet Gynecol Surv 2011;66:710-716.
[PubMed]
https://doi.org/10.1097/OGX.0b013e31823e0c44
11.
Gonzalez-Bosquet J, Terstriep SA, Cliby WA, et al.: The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol 2010;116: 419-423.
[PubMed]
https://doi.org/10.1016/j.ygyno.2009.10.053
12.
Wu TI, Hsu KH, Huang HJ, et al.: Prognostic factors and adjuvant therapy in uterine carcinosarcoma. Eur J Gynaecol Oncol 2008;29:483-488.
[PubMed]
13.
Kumaraswamy BV: Ayurvedic identification and conceptual analysis of cancer. Anc Sci Life 1994;13: 218-231.
[PubMed]
14.
Gundeti MS, Sisodia BS, Marlewar S, Reddy RG: Consultative workshop on integrative approach to cancer. Anc Sci Life 2012;3:230-231.
[PubMed]
15.
Sriram S: Patanjali - Das Yogasutra. Bielefeld, Theseus, 2006.
16.
Pal SS, Chakraborti SK, Banerjee AA, Mukerji BB: Search for anti-cancer drugs from Indian medicinal plants (Ayurvedic, Unani, etc.). Indian J Med Res 1968;56:445-455.
[PubMed]
17.
Poojari RJ, Patil AG, Gota VS: Development of botanical principles for clinical use in cancer: where are we lacking? J Postgrad Med 2012;58:63-67.
[PubMed]
https://doi.org/10.4103/0022-3859.93257
18.
Yun YH, Lee MK, Park SM, et al.: Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study. Ann Oncol 2013;24:489-494.
[PubMed]
https://doi.org/10.1093/annonc/mds469
19.
Zeller T, Münstedt K, Stoll C, et al.: Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 2013;139:357-365.
[PubMed]
https://doi.org/10.1007/s00432-012-1336-6
20.
Chandwani KD, Ryan JL, Peppone LJ, et al.: Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med 2012;2012:979213.
[PubMed]
https://doi.org/10.1155/2012/979213
21.
Pineda MJ, Singh DK: What is integrative oncology and can it help my patients? Obstet Gynecol Clin North Am 2012;39:285-312.
[PubMed]
https://doi.org/10.1016/j.ogc.2012.03.001
22.
Raveendran Nair PK, Melnick SJ, Wnuk SF, et al.: Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium. J Ethnopharmacol 2009;122:450-456.
[PubMed]
https://doi.org/10.1016/j.jep.2009.02.001
23.
Xiao D, Zeng Y, Prakash L, et al.: Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase. Mol Pharmacol 2011;79:499-507.
[PubMed]
https://doi.org/10.1124/mol.110.068551
24.
Paranjpe P: Indian Medicinal Plants. Delhi, Chaukhamba Sanskrit Pratishthan Publishers, 2005.
25.
Patil Kalpana S, Bhardwaj LK, Juvatkar PV, et al.: Plant products potential as anti-angiogenic and in cancer management. IJRAP 2010;1:339-349.
https://doi.org/10.7897/2277-4343
26.
Schrott E, Ammon HPT: Heilpflanzen der ayurvedischen und der westlichen Medizin. Heidelberg, Springer, 2012, pp 164-165.
https://doi.org/10.1007/978-3-642-13125-7
27.
Vayalil Praveen KPK, Kuttan Girija G, Kuttan Ramadasan R: Protective effects of Rasayanas on cyclophosphamide- and radiation-induced damage. J Altern Complement Med 2002;8:787-796.
[PubMed]
https://doi.org/10.1089/10755530260511801
28.
Côté A, Daneault S: Effect of yoga on patients with cancer: our current understanding. Can Fam Physician 2012;58:475-479.
[PubMed]
29.
Boehm K, Ostermann T, Milazzo S, et al.: Effects of yoga interventions on fatigue: a metaanalysis. Evid Based Complement Alternat Med 2012;2012:124703.
[PubMed]
https://doi.org/10.1155/2012/124703
30.
Dhruva A, Miaskowski C, Abrams D, et al.: Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J Altern Complement Med 2012;18:473-479.
[PubMed]
https://doi.org/10.1089/acm.2011.0555
31.
Lin KY, Hu YT, Change KJ: Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis. Evid Based Complement Alternat Med 2011;2011:659876.
[PubMed]
https://doi.org/10.1155/2011/659876
32.
Inrhaoun H, Kullmann T, Elghissassi I, et al.: Treatment of chemotherapy-induced nausea and vomiting. J Gastrointest Cancer 2012;43:541-546.
[PubMed]
https://doi.org/10.1007/s12029-012-9401-6
33.
Boccia RV, Clark G, Howell JD: Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy. Cancer Manag Res 2012;4:171-176.
[PubMed]
https://doi.org/10.2147/CMAR.S31349
34.
Fernandez-Ortega P, Caloto MT, Chirveches E, et al.: Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life. Support Care Cancer 2012;20:3141-3148.
[PubMed]
https://doi.org/10.1007/s00520-012-1448-1
35.
Hilarius DL, Kloeg PH, van der Wall E, et al.: Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer 2012;20:107-117.
[PubMed]
https://doi.org/10.1007/s00520-010-1073-9
36.
Höckel M, Wilmer A, Jaehde U: Fatigue-Syndrom bei Krebspatienten. Medizinische Monatsschrift für Pharmazeuten 2012;35;172-179.
[PubMed]
37.
Llambrich C, Falcou MC, De Rycke Y, et al.: Cancer du sein et syndrome mains-pieds. Soins 2012;766: 25-28.
[PubMed]
https://doi.org/10.1016/j.soin.2012.04.015
38.
Thoms KM, Kretschmer L: Dermatologische Nebenwirkungen in der Tumortherapie. Journal der Deutschen Dermatologischen Gesellschaft 2012;10: 451-452.
[PubMed]
https://doi.org/10.1111/j.1610-0387.2012.07977.x
39.
Haniadka R, Popouri S, Palatty PL, et al.: Medicinal plants as antiemetics in the treatment of cancer: a review. Integr Cancer Ther 2012;11:18-28.
[PubMed]
https://doi.org/10.1177/1534735411413266
40.
Das D, Agarwal SK, Chandola HM: Protective effect of Yashtimadhu (Glycyrrhiza glabra) against side effects of radiation/chemotherapy in head and neck malignancies. Ayu 2011;32:196-199.
[PubMed]
https://doi.org/10.4103/0974-8520.92579
41.
Vyas P, Thakar AB, Baghel MS, et al.: Efficacy of Rasayana Avaleha as adjuvant to radiotherapy and chemotherapy in reducing adverse effects. Ayu 2010;31:417-423.
[PubMed]
https://doi.org/10.4103/0974-8520.82029
© 2014 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.